PDHK – application of off-rate screening (ORS)2019-04-26T13:32:56+00:00

Project Description

Pyruvate dehydrogenase kinase (PDHK) – application of off-rate screening in the identification of novel pan-isoform inhibitors

Brough et al., J. Med. Chem. 2017

Moore et al., Oncotarget 2014

Libraries of non-purified resorcinol amide derivatives were screened by surface plasmon resonance (SPR) to determine the binding dissociation constant (off-rate, KD) for compounds binding to the pyruvate dehydrogenase kinase (PDHK) enzyme. Parallel off-rate measurements against HSP90 and application of structure-based drug design enabled rapid hit to lead progression in a program to identify pan-isoform ATP-competitive inhibitors of PDHK. Lead optimisation identified selective, sub-100 nM inhibitors of the enzyme, such as VER-246808, which significantly reduced phosphorylation of the E1α subunit in the PC3 cancer cell line in vitro.

Read more

This website uses cookies and third party services. Read our Privacy Policy Ok